What is another name for the blood disorder Emmanuel Ntima Weyi founded a non-profit in support of?
Sickle-cell disease Sickle-cell disease (SCD) is a group of blood disorders typically inherited from a person's parents. The most common type is known as sickle-cell anaemia (SCA). It results in an abnormality in the oxygen-carrying protein haemoglobin (hemoglobin S) found in red blood cells. This leads to a rigid, sickle-like shape under certain circumstances. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain ("sickle-cell crisis"), anemia, swelling in the hands and feet, bacterial infections, and stroke. Long term pain may develop as people get older. The average life expectancy in the developed world is 40 to 60 years.
International Trachoma Initiative International Trachoma Initiative (ITI) is a US-based non-profit organization committed to the elimination of blinding trachoma, the most common cause of preventable blindness. Founded in 1998 by the Edna McConnell Clark Foundation and Pfizer Inc, ITI has operated in 14 developing countries in Africa and Southeast Asia. ITI builds on growing international momentum to support the World Health Organization’s goal of eliminating blinding trachoma as a public health concern by 2020. Working in countries where the WHO has documented widespread disease, ITI catalyzes partnerships among international agencies and governmental and non-governmental organizations. ITI supports national governments in their efforts to implement sustainable trachoma control programs using the WHO-recommended SAFE strategy, which includes: